08:00 , Feb 8, 2016 |  BC Week In Review  |  Company News

Bioventix, CardiNor deal

Bioventix will develop and provide antibodies for CardiNor’s Secretoneurin in vitro diagnostic (IVD) test. Secretoneurin is a neuropeptide shown to be an independent risk marker of cardiovascular disease. CardiNor plans to launch its test in...
08:00 , Nov 16, 2015 |  BC Week In Review  |  Financial News

CardiNor completes venture financing

CardiNor A/S , Oslo, Norway   Business: Diagnostic   Date completed: 2015-11-10   Type: Venture financing   Raised: $750,000   Investors: Inven2; company management; company directors  ...